Bio Green Med Solution (BGMS) Cash from Investing Activities Growth (1y) (2011 - 2023)
Powered by 
Analysis
Bio Green Med Solution (BGMS) Cash from Investing Activities Growth (1y) (2011 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.56 Bn | 133.71 Bn | 2.84 Bn | 90.55% |
| 2 | Regeneron Pharmaceuticals | 87.63 Bn | 79.64 Bn | 3.93 Bn | 91.53% |
| 3 | Argenx Se | 64.65 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.24 Bn | 55.10 Bn | 52.00 Mn | -41.67% |
| 5 | Revolution Medicines | 44.13 Bn | 44.13 Bn | - | - |
| 6 | BeOne Medicines | 40.46 Bn | 35.36 Bn | 1.53 Bn | 25.90% |
| 7 | Alnylam Pharmaceuticals | 35.86 Bn | 32.56 Bn | 992.69 Mn | -157.08% |
| 8 | Royalty Pharma | 28.00 Bn | 27.16 Bn | - | 26.37% |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | -89.24% |
| 10 | Bio Green Med Solution | 4.68 Mn | 886,595.10 | 79,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | -50.00% |
| Jun 30, 2022 | -104.84% |
| Mar 31, 2022 | 94.87% |
| Dec 31, 2021 | 95.24% |
| Sep 30, 2021 | 82.00% |
| Mar 31, 2021 | -1,850.00% |
| Dec 31, 2020 | -800.00% |
| Sep 30, 2020 | -1,150.00% |
| Mar 31, 2020 | -114.81% |
| Dec 31, 2019 | 200.00% |
| Sep 30, 2019 | -100.00% |
| Jun 30, 2019 | 88.89% |
| Mar 31, 2019 | 222.73% |
| Dec 31, 2018 | -200.00% |
| Sep 30, 2018 | 77.78% |
| Mar 31, 2018 | -1,000.00% |
| Dec 31, 2015 | -20.22% |
| Sep 30, 2015 | 92.91% |
| Jun 30, 2015 | -112.90% |
| Mar 31, 2015 | -86.15% |